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Conclusion: A high prevalence of PMQR among clinical isolates of
Enterobacteriaceae producing DHA-type-pAmpC and those producing
VIM-1 was observed. A correlation between qnrB4 and DHA-type-
production was also observed as well as between qnrD and P. mirabilis
producing CMY-2.
P1737 Beta-lactams and trimethoprim induce the expression of
qnrB and smaqnr genes by SOS depending regulation
A. Briales*, J.M. Rodrı´guez-Martı´nez, P. Diaz de Alba, C. Velasco,
J. Machuca, J. Bla´zquez, A. Pascual (Seville, Madrid, ES)
Objectives: Direct SOS-depending regulation, mediated by LexA, of
qnrB genes by fluoroquinolones (FQ) has been recently reported.
smaqnr gene, from the chromosomal of Serratia marcescens, contains a
putative LexA box. The aim of this study was to evaluate whether
smaqnr gene is induced via a SOS depending mechanism, and to
investigate whether others antimicrobial agents induce the expression of
qnrB and smaqnr leading to low-level of FQ resistance.
Methods: Serratia marcescens 257 reference strain (Institute Pasteur)
and Escherichia coli J53 carrying a natural plasmid that harboured
qnrB1 were used for RT-PCR assays. Expression of smaqnr and qnrB
genes were studied by real time RT-PCR and quantified compared to
rpoB gene for S. marcescens and mdH gene for E. coli. Ceftazidime
(CAZ) at MIC concentration was tested as possible inducer. Strains
were grown to exponential phase at 37°C and the inducer was added
during 45 minute, leaving one culture as control. Additionally,
promoter regions of qnrB and smaqnr were cloned in pMS201, fused
to GPF protein and used for gene report assays. Three E. coli wild-type
strains (MG1655, ATCC25922 and DR1) and E. coli HB101 (recA
deficient and isogenic with DR1) were used for these assays. Controls
using the promoter region of recA and the empty vector were included.
Disk diffusion and E-test were used to evidence the induction with
ciprofloxacin (CIP), betalactams, trimethoprim (TMP), imipenem (IP)
and colistin (CS). Mytomycin C was used as positive control for
induction.
Results: RT-PCR assays showed that both qnrB and smaqnr were
induced at MIC of CAZ increasing transcription 2- and 3.5-fold
compared to the basal expression, in E. coli and S. marcescens,
respectively. Gene report assays showed that qnrB and smaqnr genes
were induced by CIP, as expected, but also by (CAZ), cefepime (FEP),
ampicillin or TMP in the E. coli wild-type strains, but not in the recA-
deficient E. coli HB101. Induction was not evident for IP or CS in any
case. Fluorescent quantification showed that CIP, CAZ and FEP
increased the level of expression 55%, 65% and 74% for qnrB and 44%,
60% and 68% for smaqnr, compared to recA expression.
Conclusions: Betalactams and trimethoprim induce the transcription of
qnrB and smaqnr genes by a SOS depending regulation. These results
show a direct SOS-dependent regulation of a low-level FQ-resistance
mechanism in response to others antimicrobials. Its consequences in
terms of cross resistance are currently unknown.
P1738 Identification of the new variant QepA3, a plasmid-
mediated quinolone resistance determinant, collected in a
CMY-2-producing Escherichia coli
M. Caniça, V. Manageiro*, D. Jones-Dias, D. Fe´lix,
E. Ferreira (Lisbon, PT)
Objectives: The efflux pump QepA confers decreased susceptibility to
hydrophilic fluoroquinolones (e.g., norfloxacin, ciprofloxacin, and
enrofloxacin). In this study, we characterized the third variant, named
qepA3, collected from an Escherichia coli isolate in Portugal.
Methods: INSRA6015 was isolated in 2005 from the urine of a 77-
year-old female patient hospitalized at the Hospital Fernando Fonseca,
Portugal. Susceptibility testing was performed by disk diffusion and
MIC methods, (SFM and EUCAST guidelines, respectively). PCR and
sequencing were used to screen and identify bla (blaTEM, blaSHV,
blaOXA, blaCTX-M and plasmid-mediated ampC) genes, as well as
plasmid-mediated quinolone resistance (qnrA, qnrB, qnrC, qnrD, qnrS,
qepA and aac(6¢)Ib-cr), and the quinolone resistance-determining
regions (QRDR: gyrA, gyrB, parC, and parE) genes. PCR-mapping
was used to characterize the genetic environment of the new qepA3
gene. Transfer of resistance of the QepA3 determinant, was performed
through electroporation, using the E. coli TOP10 as recipient. Plasmid
content was characterized by PCR-based replicon typing.
Results: Molecular characterization of INSRA6015 showed the
presence of blaTEM-1, blaCMY-2 and a new variant of qepA
possessing two nucleotide substitutions, leading to Phe85Leu and
Val134Ile changes. This variant, named QepA3, conferred a similar
phenotype to that of the QepA1 and QepA2 determinants. Sequencing
of the QDRD detected substitutions Ser83Leu and Asp87Asn in the
GyrA subunit and Glu84Lys in the ParC subunit, which are consistent
with the high resistance to ciprofloxacin observed in the MICs.
Sequence analysis of qepA3 genetic environment revealed that the gene
was located inside a genetic structure identical to that of previously
described for qepA1 and qepA2. It is noteworthy that qepA3 gene, as
qepA2, was not associated with the rmtB gene encoding an
aminoglycoside ribosomal methylase, contrarily to qepA1. PCR-based
replicon typing indicated the presence of the IncF plasmid.
Conclusion: We have identified and characterized a new variant of the
plasmid-mediated efflux pump QepA, which is responsible for the
increased levels of resistance to several clinically important quinolones,
such as ciprofloxacin, and norfloxacin. This is, at our knowledge, the
first description of the co-production of QepA and CMY-2. The study
highlights the need of surveillance of this resistance mechanism and
reinforces a more careful use of quinolones.
P1739 High prevalence of fluoroquinolone efflux pump OqxAB
in ESBL-producing Klebsiella pneumoniae in Spain
J.M. Rodrı´guez-Martı´nez*, P. Diaz de Alba, J. Machuca, A. Briales,
J. Rodriguez-Ban˜o, L. Martı´nez-Martı´nez, A. Pascual (Seville,
Santander, ES)
Objectives: Plasmid-mediated quinolone resistance is an emergent
phenomenon, especially in Enterobacteriaceae, and includes
mechanisms of target protection (qnr), antimicrobial inactivation
(aac(6¢)-Ib-cr) or active efflux systems (qepA and oqxAB). The efflux
pump OqxAB-TolC was originally described in E. coli and later in K.
pneumoniae. The aims of this study were (i) to analyze the presence of
oqxA and oqxB genes in a collection of ESBL-producing K.
pneumoniae strains, (ii) to determine its chromosomal and/or
plasmidic location and (iii) to analyze their expression levels in
relation to susceptibility or resistance to quinolones.
Methods: A collection of 114 non-repetitive isolates of ESBL-
producing K. pneumoniae from a multicenter study in Spain was
used. 37.8% of isolates were susceptible to ciprofloxacin (CIP), while
62.2% were resistant or intermediate. Detection of oqxA and oqxB
genes was performed by PCR. Chromosomal and/or plasmidic location
was performed using plasmid DNA (Kieser technique) and subsequent
hybridization. oqxA gene expression was analyzed by real time RT-
PCR. Normalized expression levels of the target gene transcripts were
calculated in comparison to the expression of rpoB using the 2 -DDCT
method. K. pneumoniae ATCC 27799 and K. pneumoniae ATCC
700603 were included in the study.
Results: Both oqxA and oqxB were detected in K. pneumoniae at high
prevalence, 77% and 75% respectively. Ten amplicons were sequenced
and showed 100% homology with previously described genes showing
a high degree of conservation. Hybridization assays showed the
simultaneous presence of oqxA (16%) and oqxB (13%) in both
chromosome and large size plasmids locations. These plasmids were
not transferable by transformation into E. coli. RT-PCR assays showed
a higher expression (four-folds) in strains with reduced susceptibility to
quinolones compared to that of susceptible strains. Interestingly, K.
pneumoniae ATCC 700603 showed an 18-folds higher expression than
K. pneumoniae ATCC 27799. These differences were in accordance to
the MICs of CIP (0.5 and 0.125 mg/L, respectively).
News on fluoroquinolone resistance 485
